Preliminary Phytochemical Characterization of Eucalyptus Oil with Implications for Respiratory Therapeutics
Rahul Choudhary, Sharuti, Prikshit Kumar, Inder Kumar*
Minerva College of Pharmacy, Indora, Kangra, Himachal Pradesh, India.
*Corresponding Author E-mail: inder.93kumar@gmail.com
ABSTRACT:
Eucalyptus oil is a well-known natural product widely used for its therapeutic properties, particularly in the treatment of respiratory disorders. The present study aims to perform a preliminary phytochemical characterization of Eucalyptus oil obtained through hydrodistillation and to evaluate its potential implications in respiratory therapeutics. The extracted oil was subjected to standard qualitative phytochemical screening to identify major bioactive constituents. The results indicated the strong presence of terpenoids, along with significant amounts of flavonoids, tannins, and phenolic compounds. Glycosides were found to be moderately present, while alkaloids were detected only in trace amounts, and saponins were absent. The predominance of terpenoids, especially eucalyptol (1,8-cineole), plays a crucial role in the pharmacological activity of Eucalyptus oil. These compounds exhibit potent expectorant, bronchodilator, anti-inflammatory, and antimicrobial properties, making the oil highly effective in managing respiratory conditions such as cough, cold, bronchitis, and sinusitis. Furthermore, the presence of phenolic compounds and flavonoids enhances antioxidant activity, which helps in reducing oxidative stress and protecting respiratory tissues. Overall, the findings support the traditional use of Eucalyptus oil in respiratory care and highlight its potential as a natural therapeutic agent. Further studies involving detailed quantitative analysis, formulation development, and clinical evaluation are recommended to validate its efficacy and safety for broader medical applications.
KEYWORDS: Eucalyptus oil, Hydrodistillation, Phytochemical screening, Terpenoids; Eucalyptol, Flavonoids, Respiratory therapeutics.
INTRODUCTION:
Essential oils (EOs) are extracted from various plant parts, such as wood, leaves, roots, flowers, and fruits, using steam or hydro-distillation techniques. These oils are complex combinations of terpenic chemicals, mainly monoterpenes and sesquiterpenes, along with alcohols, aldehydes, ethers, esters, ketones, and phenols, which contribute to their distinctive scents.1 The Eucalyptus species comprises over 900 species and subspecies, is native to Australia and has been successfully cultivated in various regions with subtropical and Mediterranean climates. Eucalyptus, a member of the Myrtaceae family, is a fast-growing tree that reaches a height of up to 25-50 meters. This tree can grow in wide climatic conditions, and thrives best in tropical to temperate conditions. This tree can tolerate drought stress, hence can be cultivated in drought areas and wastelands with a temperature range from 0-47°C. The leaves of this plant are used to extract Oleum Eucalypti (Eucalyptus oil) worldwide.2
One of the most widely used species for medicinal purposes is Eucalyptus globulus (commonly called Blue Gum). The leaves of eucalyptus contain volatile oil, mainly Eucalyptol (1,8‑cineole), which is responsible for its characteristic aroma and therapeutic effects. This compound exhibits antimicrobial, anti-inflammatory, and expectorant properties, making eucalyptus oil useful in the treatment of respiratory disorders such as cough, cold, bronchitis, and asthma.3 With regard to the cure of these highly treatable respiratory diseases, the World Health Organization (WHO) is promoting herbal medicine and pharmacological research to make better use of herbal remedies. The use of herbal remedies for the treatment of respiratory disorders is a common practice in many parts of the world.4
Traditional medicine has been an important source of products for developing countries in treating common infections. Medicinal plants are very vital in their uses for medication, besides providing ecological, economic, and cultural services. The world’s primary means of treating diseases and fighting infections has been based on the use of medicinal plants. From ancient times, plants have been a rich source of effective and safe medicines. In the world, 64% of the population relies on medicinal plants to treat health problems.5 Medicinal plants are widely used for the treatment of various diseases. Eucalyptus globulus is a medicinal plant widely used in traditional and modern medicine for the treatment of respiratory disorders. The essential oil obtained from its leaves is rich in bioactive compounds, particularly monoterpenes such as 1,8-cineole, which exhibit bronchodilatory, anti-inflammatory, and antimicrobial properties.6 Due to these therapeutic benefits, eucalyptus oil is commonly used for cough, cold, asthma, and sinusitis. Preliminary phytochemical characterisation is important to identify the major chemical constituents responsible for its pharmacological activity and to ensure quality and efficacy in respiratory therapeutics.7
MATERIAL AND METHODS:
The Eucalyptus officinalis plant leaves were collected from the Indora region of Himachal Pradesh. The plant was confirmed by CSK Himachal Pradesh Agriculture University, Palampur, India. All other chemicals and solvents were purchased from CDH (P) Ltd and were of analytical grade.
METHODOLOGY:
Fresh eucalyptus leaves were collected, washed, shade-dried, and powdered. Eucalyptus oil was extracted using hydrodistillation with a Clevenger apparatus. The obtained oil was dried and stored in airtight containers.8 Preliminary phytochemical tests were performed to identify major constituents such as terpenoids, flavonoids, and phenolic compounds. The phytochemical profile was analyzed to understand the potential role of eucalyptus oil in respiratory disorders like cough, cold, and bronchitis.9
Preparation of Plant Material:
Preparation of plant material is an important step before the extraction of eucalyptus oil. Proper preparation ensures the quality, purity, and maximum yield of essential oil during the hydrodistillation process.10
1. Collection of Plant Material:
Fresh and healthy leaves of Eucalyptus globulus are collected from mature eucalyptus trees. The leaves should be free from disease, dust, and insect damage.11
2. Cleaning:
The collected leaves are washed thoroughly with distilled water to remove dust, soil, and other impurities. After washing, the leaves are allowed to dry at room temperature.12
3. Drying:
The leaves are dried in shade at room temperature for several days to remove excess moisture. Shade drying helps in preserving the volatile compounds present in the plant.13
4. Size Reduction:
The dried leaves are cut or crushed into small pieces using a clean knife or grinder. This increases the surface area, which helps in the efficient extraction of essential oil.14
5. Storage:
The prepared plant material is stored in clean, dry, airtight containers until it is used for the extraction process.15
6. Weighing:
A required amount of the prepared leaves (for example, 100–200 g) is weighed using a digital balance before starting the hydrodistillation process.16
7. Hydrodistillation:
Hydrodistillation is a method used to extract essential oils from plant materials by boiling them in water. The volatile components evaporate with steam and are then condensed back into liquid form, allowing separation of the essential oil from the water.17
Phytochemical Screening:
In phytochemical screening, the diluted product was synchronized with different reagents to identify the nature of the plant. The plant’s substitute was tested for the presence of flavonoids, tannins, and vitamin A by various methods. 2-3ml of the product sample was taken in different test tubes and for different chemical testing; the sample was treated with different solvents to check the presence or absence of specified chemical strains in the plant, using Standard methods as described in the table 1.18
Table 1: Preliminary Phytochemical Screening for Plant Extracts19,20
|
S. No. |
Phytoconstituents |
Tests |
Observations |
|
1 |
Flavonoids |
Extract + Lead acetate solution |
Yellow precipitate |
|
Extract + NaOH solution |
Intense yellow color |
||
|
Extract + Mg ribbon + Conc. HCl (Shinoda test) |
Pink/red color |
||
|
Extract + Ammonia solution |
Yellow fluorescence |
||
|
Extract + AlCl₃ solution |
Yellow fluorescence |
||
|
Extract + Zn + HCl (Reduction test) |
Red coloration |
||
|
Extract + Ferric chloride |
Greenish color |
||
|
Extract + Sulfuric acid |
Orange color |
||
|
2 |
Glycosides |
Keller–Killiani test |
Brown ring at the interface |
|
Fehling’s test (after hydrolysis) |
Brick red precipitate |
||
|
Benedict’s test (after hydrolysis) |
Orange-red precipitate |
||
|
Legal’s test |
Pink/red color |
||
|
Borntrager’s test |
Pink/red in the ammonia layer |
||
|
Modified Borntrager’s test |
Rose pink color |
||
|
Baljet test |
Orange colour |
||
|
Sodium nitroprusside test |
Red color |
||
|
3 |
Tannins |
Extract + Ferric chloride (5%) |
Blue-black/green color |
|
Extract + Gelatin solution |
White precipitate |
||
|
Extract + Lead acetate |
White precipitate |
||
|
Extract + Potassium dichromate |
Red precipitate |
||
|
Extract + Vanillin + HCl |
Red color |
||
|
Goldbeater’s skin test |
Brown/black color |
||
|
Extract + Bromine water |
Decolorization |
||
|
Extract + Dilute iodine |
Faint red color |
||
|
4 |
Phenolic Compounds |
Extract + Ferric chloride |
Deep blue/black color |
|
Extract + Lead acetate |
White precipitate |
||
|
Extract + Potassium permanganate |
Decolorization |
||
|
Folin–Ciocalteu reagent |
Blue color |
||
|
Ellagic acid test |
Muddy brown ppt |
||
|
Extract + Ammonia |
Yellow color |
||
|
Extract + Nitric acid |
Yellow nitration color |
||
|
5 |
Terpenoids |
Salkowski test (Chloroform + Conc. H₂SO₄) |
Reddish-brown interface |
|
Liebermann–Burchard test |
Blue-green color |
||
|
Copper acetate test |
Emerald green color |
||
|
Noller’s test |
Purple color |
||
|
Extract + Tin + Thionyl chloride |
Pink color |
||
|
Extract + Acetic anhydride + H₂SO₄ |
Color change (blue/green) |
||
|
6 |
Alkaloids |
Dragendorff’s reagent |
Orange/red precipitate |
|
Mayer’s reagent |
Cream precipitate |
||
|
Wagner’s reagent |
Brown/reddish precipitate |
||
|
Hager’s reagent |
Yellow precipitate |
||
|
Tannic acid test |
Buff precipitate |
||
|
Picric acid test |
Yellow crystalline ppt |
||
|
Phosphomolybdic acid test |
Yellow ppt |
||
|
Iodine test |
Brown precipitate |
||
|
7 |
Saponins |
Froth test (shake with water) |
Persistent foam |
|
Foam test |
Stable froth |
||
|
Emulsion test (with oil) |
Stable emulsion |
||
|
Hemolysis test |
RBC lysis (clear zone) |
||
|
Sodium bicarbonate test |
Honeycomb froth |
||
|
Olive oil test |
Emulsion formation |
||
|
Blood agar test |
Hemolytic zone |
||
|
Foam persistence test (15 min) |
Stable foam |
|
S. No. |
Phytoconstituent |
Test |
Observation |
Result |
|
1 |
Flavonoids |
Lead acetate |
Yellow ppt |
++ |
|
NaOH test |
Intense yellow |
++ |
||
|
Shinoda test |
Pink/red |
++ |
||
|
Ammonia test |
Yellow fluorescence |
++ |
||
|
AlCl₃ test |
Yellow fluorescence |
++ |
||
|
Zn + HCl |
Red color |
+ |
||
|
Ferric chloride |
Greenish |
+ |
||
|
H₂SO₄ |
Orange |
+ |
||
|
2 |
Glycosides |
Keller–Killiani |
Brown ring |
+ |
|
Fehling’s |
Brick red ppt |
+ |
||
|
Benedict’s |
Orange-red ppt |
+ |
||
|
Legal’s test |
Pink/red |
+ |
||
|
Borntrager’s |
Pink/red layer |
+ |
||
|
Modified Borntrager’s |
Rose pink |
+ |
||
|
Baljet test |
Orange |
+ |
||
|
Sodium nitroprusside |
Red |
± |
||
|
3 |
Tannins |
Ferric chloride |
Blue-black/green |
++ |
|
Gelatin test |
White ppt |
++ |
||
|
Lead acetate |
White ppt |
++ |
||
|
K₂Cr₂O₇ |
Red ppt |
+ |
||
|
Vanillin + HCl |
Red |
+ |
||
|
Goldbeater’s skin |
Brown/black |
++ |
||
|
Bromine water |
Decolorization |
+ |
||
|
Iodine test |
Faint red |
± |
||
|
4 |
Phenolics |
Ferric chloride |
Deep blue/black |
++ |
|
Lead acetate |
White ppt |
++ |
||
|
KMnO₄ |
Decolorization |
++ |
||
|
Folin–Ciocalteu |
Blue |
++ |
||
|
Ellagic acid |
Muddy brown ppt |
+ |
||
|
Ammonia |
Yellow |
+ |
||
|
HNO₃ |
Yellow |
+ |
||
|
5 |
Terpenoids |
Salkowski |
Reddish-brown ring |
++ |
|
Liebermann–Burchard |
Blue-green |
++ |
||
|
Copper acetate |
Emerald green |
++ |
||
|
Noller’s test |
Purple |
++ |
||
|
Tin + SOCl₂ |
Pink |
+ |
||
|
Acetic anhydride + H₂SO₄ |
Blue/green |
++ |
||
|
6 |
Alkaloids |
Dragendorff’s |
Faint ppt |
± |
|
Mayer’s |
Slight ppt |
± |
||
|
Wagner’s |
Weak brown ppt |
± |
||
|
Hager’s |
Yellow ppt (trace) |
± |
||
|
Tannic acid |
Buff ppt |
± |
||
|
Picric acid |
Yellow ppt |
± |
||
|
Phosphomolybdic acid |
Yellow ppt |
± |
||
|
Iodine |
Brown ppt |
± |
||
|
7 |
Saponins |
Froth test |
No foam |
− |
|
Foam test |
Unstable froth |
− |
||
|
Emulsion test |
No emulsion |
− |
||
|
Hemolysis |
No clearing |
− |
||
|
NaHCO₃ |
No froth |
− |
||
|
Olive oil |
No emulsion |
− |
||
|
Blood agar |
No hemolysis |
− |
||
|
Foam persistence |
No stable foam |
− |
++ = Strongly present, + = Moderately present, ± = Trace / less present, − = Absent
These tests showed the presence of several bioactive secondary metabolites, which might be responsible for their medicinal attributes. The observations and implications made in the phytochemical tests are presented as follows:
Flavonoids present in Eucalyptus contribute to respiratory health through their strong antioxidant and anti-inflammatory properties. They help reduce inflammation in the airways, making them beneficial in conditions like asthma and bronchitis. They also protect lung tissues from oxidative stress.24
Glycosides found in Eucalyptus support respiratory function by exhibiting mild expectorant and antimicrobial effects. They help in loosening mucus and facilitating its removal from the respiratory tract, thereby improving breathing.25
Tannins contribute to respiratory health due to their astringent and antimicrobial properties. They help reduce irritation in the throat and respiratory tract and may provide relief from cough and minor respiratory infections.26
Phenolic Compounds:
Phenolic compounds play a major role in respiratory therapy by providing antioxidant and anti-inflammatory effects. They help protect lung tissues, reduce airway inflammation, and prevent damage caused by free radicals, especially in chronic respiratory diseases.27
Terpenoids are the most important constituents for respiratory benefits in Eucalyptus. Compounds like cineole (eucalyptol) act as powerful expectorants, bronchodilators, and antiseptics. They help clear mucus, open airways, and provide relief in conditions such as cough, cold, sinusitis, and bronchitis.28
Alkaloids are generally absent or present in trace amounts in Eucalyptus, so they do not play any significant role in respiratory activity.29
Saponins are typically absent in Eucalyptus. Therefore, they do not contribute significantly to respiratory therapeutic effects in this plant.30
CONCLUSION:
The present study investigated the preliminary phytochemical composition of eucalyptus oil extracted from the leaves of Eucalyptus globulus using hydrodistillation followed by qualitative phytochemical screening. The results confirmed the presence of several important secondary metabolites, including terpenoids, phenolic compounds, flavonoids, tannins, and alkaloids, which are known to contribute to the medicinal properties of eucalyptus oil. Among these constituents, terpenoids were found to be the predominant compounds, particularly Eucalyptol, which has been widely reported for its anti-inflammatory, antimicrobial, expectorant, and bronchodilator activities. These properties support the traditional use of eucalyptus oil in the management of respiratory disorders such as Bronchitis, Asthma, and the common cold. The presence of phenolic compounds and flavonoids indicates potential antioxidant and antimicrobial activities, while tannins and alkaloids may also contribute to the overall therapeutic effects. These phytochemicals collectively enhance the pharmacological value of eucalyptus oil and support its potential application in respiratory therapeutics.
1. Tomé M, Almeida MH, Barreiro S, Branco MR, Deus E, Pinto G, et al. Opportunities and challenges of Eucalyptus plantations in Europe: The Iberian Peninsula experience. Eur J For Res. 2021; 140(3): 489–510.
2. Lee SH, Lum WC, Antov P, Krišt’ák L, Rahandi Lubis MA, Fatriasari W. Eucalyptus. Springer; 2024. 554–560 p.
3. Shiekh RA El, Atwa AM, Elgindy AM, Mustafa AM, Senna MM, Alkabbani MA, et al. Therapeutic applications of eucalyptus essential oils: RA El Shiekh et al. Inflammopharmacology. 2025; 33(1): 163–82.
4. Hirsch H, Allsopp MH, Canavan S, Cheek M, Geerts S, Geldenhuys CJ, et al. Eucalyptus camaldulensis in South Africa–past, present, future. Trans R Soc South Africa. 2020; 75(1): 1–22.
5. Alemayehu A, Melka Y. Small scale eucalyptus cultivation and its socioeconomic impacts in Ethiopia: A review of practices and conditions. Trees, For People. 2022; 8(2): 100269.
6. Hutapea FJ, Weston CJ, Mendham D, Volkova L. Sustainable management of Eucalyptus pellita plantations: A review. For Ecol Manage. 2023; 537(6): 120941.
7. Almas I, Innocent E, Machumi F, Kisinza W. Chemical composition of essential oils from Eucalyptus globulus and Eucalyptus maculata grown in Tanzania. Sci African. 2021; 12(3): e00758.
8. Khedkar DD. Plant products and essential oil therapy for treatment of new and emerging viruses. In: Fighting multidrug resistance with herbal extracts, essential oils and their components. Elsevier; 2025. p. 391–419.
9. Leigh-de Rapper S, Viljoen A, van Vuuren S. Essential oil blends: The potential of combined use for respiratory tract infections. Antibiotics. 2021;10(12): 1517.
10. GabAllah M, Shaker K, Abulhamd AT, El-Shesheny R. Synergistic Antiviral Effects of Combined Fractions from Eucalyptus camaldulensis Against SARS-CoV-2. Egypt J Chem. 2025; 68(13): 1–13.
11. Becker LC, Akinsulie A, Bergfeld WF, Belsito D V, Hill RA, Klaassen CD, et al. Safety assessment of Eucalyptus globulus (eucalyptus)-derived ingredients as used in cosmetics. Int J Toxicol. 2023; 42(1_suppl): 57S-92S.
12. Singh Y, Das KK, Thelly MT, Kumar B, Roy A. Phytochemical study and in vitro anti-diabetic activity of eucalyptus and lemon oils. Drug Anal Res. 2022; 5(2): 22–33.
13. Mondal M, Quispe C, Sarkar C, Bepari TC, Alam MJ, Saha S, et al. Analgesic and anti-inflammatory potential of essential oil of Eucalyptus camaldulensis leaf: in vivo and in silico studies. Nat Prod Commun. 2021;16(4): 1934578X211007634.
14. Sharma AD, Inderjeet K. Molecular docking and pharmacokinetic screening of eucalyptol (1, 8 cineole) from eucalyptus essential oil against SARS-CoV-2. Not Sci Biol. 2020; 12(3): 536–45.
15. Juergens LJ, Worth H, Juergens UR. New perspectives for mucolytic, anti-inflammatory and adjunctive therapy with 1, 8-cineole in COPD and asthma: review on the new therapeutic approach. Adv Ther. 2020; 37(5): 1737–53.
16. Hussain HA, Islam M, Saeed H, Ahmad A, Hussain A, Rafay MZ. Insight to phytochemical investigation and anti-hyperlipidemic effects of Eucalyptus camaldulensis leaf extract using in vitro, in vivo and in silico approach. J Biomol Struct Dyn. 2025; 43(1): 325–47.
17. Yao B, He B, Peng J, Song X, Zhao R, Sun Y, et al. The comprehensive review of eucalyptol: synthesis, metabolism, and therapeutic applications in disease treatment. Mol Biol Rep. 2025; 52(1): 346.
18. Kheder DA, Al-Habib OAM, Gilardoni G, Vidari G. Components of volatile fractions from Eucalyptus camaldulensis leaves from Iraqi–Kurdistan and their potent spasmolytic effects. Molecules. 2020; 25(4): 804.
19. Bem AA, Adamu H, Bem LS. Comparative Phytochemical Analysis and Medicinal Properties of Neem (Azadirachta indica) and Eucalyptus (Eucalyptus globulus) Plant. Sahel J Life Sci FUDMA. 2025; 3(2): 304–10.
20. Asif M, Saleem M, Saadullah M, Yaseen HS, Al Zarzour R. COVID-19 and therapy with essential oils having antiviral, anti-inflammatory, and immunomodulatory properties. Inflammopharmacology. 2020; 28(5): 1153–61.
21. Aswandi A, Kholibrina CR, Kuspradini H. Phytochemical, essential oils and product applications from Eucalyptus. In: Eucalyptus: Engineered Wood Products and Other Applications. Springer; 2023. p. 163–83.
22. Okhale SE, Oladosu PO, Aboh MI, Imoisi C, Gana JJ. In-vitro evaluation of Eucalyptus citriodora leaf essential oil and extracts on selected pathogens implicated in respiratory tract infections. Int J Pharmacogn. 2022; 9(4): 195–201.
23. Surbhi, Kumar A, Singh S, Kumari P, Rasane P. Eucalyptus: phytochemical composition, extraction methods and food and medicinal applications. Adv Tradit Med. 2023; 23(2): 369–80.
24. Singh J, Javed DS, Yadav R, Verma AK, Upadhyay DK. Review on eucalyptus: phytochemical profile, Extraction Techniques, And Pharmacological Applications In Food And Medicine. Acta Biomed. 2024; 95(1): 334–44.
25. Sharma AD, Farmaha M, Kaur I, Singh N. Phytochemical analysis using GC-FID, FPLC fingerprinting, antioxidant, antimicrobial, anti-inflammatory activities analysis of traditionally used Eucalyptus globulus essential oil. Drug Anal Res. 2021; 5(1): 26–38.
26. El-Shiekh RA, Okba MM, Mandour AA, Kutkat O, Elshimy R, Nagaty HA, et al. Eucalyptus oils phytochemical composition in correlation with their newly explored anti-SARS-CoV-2 potential: in vitro and in silico approaches. Plant Foods Hum Nutr. 2024; 79(2): 410–6.
27. Mostafa-Hedeab G, Hegazy A, Mostafa I, Eissa IH, Metwaly AM, Elhady HA, et al. In vitro antiviral activities of thymol and Limonin against influenza a viruses and SARS-CoV-2. Sci Rep. 2025; 15(1): 22587.
28. Chalannavar R. Role of botanical essential oils as a therapy for controlling coronavirus (SARS-CoV-2) disease (Covid-19). Int J Res Sci Innov. 2021; 8(4): 105–18.
29. Sri PK, Reddy TUK, Sony B, Sandhya A, Rajyalakshmi KG, Sindhu G, et al. Preparation And Evaluation Of Polyherbal Scented Candle Using Volatile Oils Extracted By Enfleurage Method. Indones J Heal Sci Res Dev. 2023; 6(1): 38–48.
30. Almeida HHS, Crugeira PJL, Amaral JS, Rodrigues AE, Barreiro MF. Disclosing the potential of Cupressus leylandii AB Jacks & Dallim, Eucalyptus globulus Labill., Aloysia citrodora Paláu, and Melissa officinalis L. hydrosols as eco-friendly antimicrobial agents. Nat Products Bioprospect. 2024; 14(1): 1.
|
Received on 22.04.2026 Revised on 11.05.2026 Accepted on 26.05.2026 Published on 08.07.2026 Available online from July 13, 2026 Res. J. Pharmacognosy and Phytochem. 2026; 18(3):243-248. DOI: 10.52711/0975-4385.2026.00035 ©A&V Publications All right reserved
|
|
|
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. Creative Commons License. |
|